apnea and alprostadil

apnea has been researched along with alprostadil in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	2 (33.33)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Gurkowski, MA; Park, MK; Rasch, DK	1
Hallidie-Smith, KA	1
Ballanyi, K; Hoch, B; Lalley, PM; Richter, DW	1
Charpie, JR; Crowley, DC; Kim, DW; Kulik, TJ; Lim, DS; Maher, KO	1
Bosser, G; Burger, G; Chipaux, M; Feillet, F; Le Tacon, S; Lethor, JP; Lucron, H; Marçon, F; Monin, P	1
Conaway, MR; Dean, PN; Elliott, MR; Haughey, BS; Swanson, JR; White, SC; Wiggin, JY	1

Trials

1 trial(s) available for apnea and alprostadil

Article	Year
Aminophylline for the prevention of apnea during prostaglandin E1 infusion. Pediatrics, 2003, Volume: 112, Issue:1 Pt 1 Topics: Alprostadil; Aminophylline; Apnea; Bradycardia; Bronchodilator Agents; Double-Blind Method; Ductus Arteriosus, Patent; Humans; Hypnotics and Sedatives; Hypoxia; Infant, Newborn; Intubation, Intratracheal; Irritable Mood; Length of Stay; Palliative Care; Prospective Studies; Survival Rate; Treatment Outcome	2003

Article

Year

Aminophylline for the prevention of apnea during prostaglandin E1 infusion.

Pediatrics, 2003, Volume: 112, Issue:1 Pt 1

Topics: Alprostadil; Aminophylline; Apnea; Bradycardia; Bronchodilator Agents; Double-Blind Method; Ductus Arteriosus, Patent; Humans; Hypnotics and Sedatives; Hypoxia; Infant, Newborn; Intubation, Intratracheal; Irritable Mood; Length of Stay; Palliative Care; Prospective Studies; Survival Rate; Treatment Outcome

2003

Other Studies

5 other study(ies) available for apnea and alprostadil

Article	Year
Apnea during prostaglandin infusion caused by intramuscular ketamine. Journal of cardiothoracic anesthesia, 1990, Volume: 4, Issue:6 Topics: Alprostadil; Apnea; Drug Interactions; Humans; Infant, Newborn; Injections, Intramuscular; Ketamine; Male; Preanesthetic Medication; Transposition of Great Vessels	1990
Prostaglandin E1 in suspected ductus dependent cardiac malformation. Archives of disease in childhood, 1984, Volume: 59, Issue:11 Topics: Alprostadil; Apnea; Blood Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Ductus Arteriosus; Heart Defects, Congenital; Humans; Infant, Newborn; Oxygen; Prostaglandins E; Pulmonary Circulation; Seizures; Vasodilator Agents	1984
cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats. The Journal of physiology, 1997, Oct-01, Volume: 504 ( Pt 1) Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Animals, Newborn; Apnea; Cyclic AMP; GTP-Binding Proteins; Nerve Net; Phosphodiesterase Inhibitors; Prostaglandins; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiratory Insufficiency; Respiratory Mechanics; Respiratory System	1997
[Complications of prostaglandin E1 treatment of congenital heart disease in paediatric medical intensive care]. Archives des maladies du coeur et des vaisseaux, 2005, Volume: 98, Issue:5 Topics: Alprostadil; Apnea; Body Weight; Enterocolitis; Exanthema; Female; France; Heart Defects, Congenital; Humans; Infant, Newborn; Intensive Care Units, Pediatric; Male; Retrospective Studies; Risk Factors; Vasodilator Agents; Vomiting	2005
Standardizing Prostaglandin Initiation in Prenatally Diagnosed Ductal-Dependent Neonates; A Quality Initiative. Pediatric cardiology, 2023, Volume: 44, Issue:6 Topics: Alprostadil; Apnea; Cardiac Surgical Procedures; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Infant, Newborn; Prostaglandins	2023